Literature DB >> 19956053

Sonographic findings of ascaris lumbricoides in the gastrointestinal and biliary tracts.

Size Wu1.   

Abstract

OBJECTIVE: Ascaris lumbricoides may obstruct bowel, biliary tree, pancreatic ducts, and appendix and induce biliary stones. The purpose of this article was to illustrate typical sonographic findings of A. lumbricoides in the gastrointestinal and biliary tracts.
METHODS: Clinical data of 57 patients undergoing sonographic examination with confirmed ascariasis were studied retrospectively, and features of sonographic characteristics of A. lumbricoides in gastrointestinal and biliary tracts were studied.
RESULTS: Sonographic characteristics of A. lumbricoides were single or multiple echogenic nonshadowing linear, tubular structures; curved strips or rodlike with or without echoic tubular central lines; and a spaghettilike appearance, a target sign, or a pseudotumor appearance in the transverse section.
CONCLUSIONS: Ascaris lumbricoides in the gastrointestinal and biliary tracts has various features. Sonographic examination in the diagnosis of ascaridiasis has a high value.

Entities:  

Mesh:

Year:  2009        PMID: 19956053     DOI: 10.1097/RUQ.0b013e3181c47a2d

Source DB:  PubMed          Journal:  Ultrasound Q        ISSN: 0894-8771            Impact factor:   1.657


  3 in total

1.  Ultrasonographic appearance of intestinal Ascaris.

Authors:  Taylan Kara
Journal:  J Med Ultrason (2001)       Date:  2012-10-03       Impact factor: 1.314

Review 2.  Resurgence of intestinal ascariasis among adults: radiological diagnosis and clinical implications.

Authors:  Gary G Ghahremani; Michael E Hahn
Journal:  Abdom Radiol (NY)       Date:  2022-01-11

Review 3.  Point-of-Care Ultrasound Assessment of Tropical Infectious Diseases--A Review of Applications and Perspectives.

Authors:  Sabine Bélard; Francesca Tamarozzi; Amaya L Bustinduy; Claudia Wallrauch; Martin P Grobusch; Walter Kuhn; Enrico Brunetti; Elizabeth Joekes; Tom Heller
Journal:  Am J Trop Med Hyg       Date:  2015-09-28       Impact factor: 2.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.